554 related articles for article (PubMed ID: 20005001)
21. Soybean allergy in patients allergic to birch pollen: clinical investigation and molecular characterization of allergens.
Mittag D; Vieths S; Vogel L; Becker WM; Rihs HP; Helbling A; Wüthrich B; Ballmer-Weber BK
J Allergy Clin Immunol; 2004 Jan; 113(1):148-54. PubMed ID: 14713921
[TBL] [Abstract][Full Text] [Related]
22. Cor a 1-reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen-associated food allergy to hazelnut.
Hofmann C; Scheurer S; Rost K; Graulich E; Jamin A; Foetisch K; Saloga J; Vieths S; Steinbrink K; Adler HS
J Allergy Clin Immunol; 2013 May; 131(5):1384-92.e6. PubMed ID: 23246018
[TBL] [Abstract][Full Text] [Related]
23. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch.
Cudowska B; Kaczmarski M; Restani P
Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981
[TBL] [Abstract][Full Text] [Related]
24. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
25. Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides.
Ebner C; Szépfalusi Z; Ferreira F; Jilek A; Valenta R; Parronchi P; Maggi E; Romagnani S; Scheiner O; Kraft D
J Immunol; 1993 Feb; 150(3):1047-54. PubMed ID: 7678615
[TBL] [Abstract][Full Text] [Related]
26. A sensitive assay for the detection of IgE bound to the major birch pollen allergen, Bet v 1, in the form of immune complexes.
Pree I; Reisinger J; Bohle B; Frantal S; Valenta R; Niederberger V
J Immunol Methods; 2009 Jun; 345(1-2):100-5. PubMed ID: 19376122
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
[TBL] [Abstract][Full Text] [Related]
28. Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors.
Bellinghausen I; Brand U; Knop J; Saloga J
J Allergy Clin Immunol; 2000 May; 105(5):988-96. PubMed ID: 10808181
[TBL] [Abstract][Full Text] [Related]
29. Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy.
Batard T; Didierlaurent A; Chabre H; Mothes N; Bussières L; Bohle B; Couret MN; Ball T; Lemoine P; Focks Tejkl M; Chenal A; Clément G; Dupont F; Valent P; Krauth MT; André C; Valenta R; Moingeon P
Int Arch Allergy Immunol; 2005 Mar; 136(3):239-49. PubMed ID: 15722633
[TBL] [Abstract][Full Text] [Related]
30. Characterization of PR-10 genes from eight Betula species and detection of Bet v 1 isoforms in birch pollen.
Schenk MF; Cordewener JH; America AH; Van't Westende WP; Smulders MJ; Gilissen LJ
BMC Plant Biol; 2009 Mar; 9():24. PubMed ID: 19257882
[TBL] [Abstract][Full Text] [Related]
31. Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1.
Vrtala S; Hirtenlehner K; Susani M; Akdis M; Kussebi F; Akdis CA; Blaser K; Hufnagl P; Binder BR; Politou A; Pastore A; Vangelista L; Sperr WR; Semper H; Valent P; Ebner C; Kraft D; Valenta R
FASEB J; 2001 Sep; 15(11):2045-7. PubMed ID: 11511511
[TBL] [Abstract][Full Text] [Related]
32. Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.
Wiedermann U; Herz U; Baier K; Vrtala S; Neuhaus-Steinmetz U; Bohle B; Dekan G; Renz H; Ebner C; Valenta R; Kraft D
Int Arch Allergy Immunol; 2001 Sep; 126(1):68-77. PubMed ID: 11641608
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the T cell response to the major hazelnut allergen, Cor a 1.04: evidence for a relevant T cell epitope not cross-reactive with homologous pollen allergens.
Bohle B; Radakovics A; Lüttkopf D; Jahn-Schmid B; Vieths S; Ebner C
Clin Exp Allergy; 2005 Oct; 35(10):1392-9. PubMed ID: 16238801
[TBL] [Abstract][Full Text] [Related]
34. Impaired maturation of monocyte-derived dendritic cells from birch allergic individuals in association with birch-specific immune responses.
Casas R; Skarsvik S; Lindström A; Zetterström O; Duchén K
Scand J Immunol; 2007 Nov; 66(5):591-8. PubMed ID: 17868259
[TBL] [Abstract][Full Text] [Related]
35. Oralair Birch, a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen.
Larenas-Linnemann D
Curr Opin Investig Drugs; 2010 May; 11(5):586-96. PubMed ID: 20419605
[TBL] [Abstract][Full Text] [Related]
36. The Clinical Impact of Bet v 6 in Birch Pollen-Sensitized Patients.
Gellrich D; Eder K; San Nicoló M; Berghaus A; Gröger M
Int Arch Allergy Immunol; 2017; 173(1):34-43. PubMed ID: 28494455
[TBL] [Abstract][Full Text] [Related]
37. Relationship between Bet v 1 and Bet v 2 specific IgE and food allergy in children with grass pollen respiratory allergy.
Ricci G; Righetti F; Menna G; Bellini F; Miniaci A; Masi M
Mol Immunol; 2005 Jun; 42(10):1251-7. PubMed ID: 15829314
[TBL] [Abstract][Full Text] [Related]
38. Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4.
Shirasaki H; Yamamoto T; Koyanagi Y; Watanabe N; Himi T
Allergol Int; 2008 Mar; 57(1):93-6. PubMed ID: 18209509
[TBL] [Abstract][Full Text] [Related]
39. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
[TBL] [Abstract][Full Text] [Related]
40. Direct contact between dendritic cells and bronchial epithelial cells inhibits T cell recall responses towards mite and pollen allergen extracts in vitro.
Papazian D; Wagtmann VR; Hansen S; Würtzen PA
Clin Exp Immunol; 2015 Aug; 181(2):207-18. PubMed ID: 25707463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
